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Does Volume Translate in Function in Interstage Associating Liver
Partition and Portal Vein Ligation for Staged Hepatectomy?
Commentary on ‘‘Drop of Total Liver Function in the Interstages of the New
Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy
Technique: Analysis of the Auxiliary Liver by Hepatobiliary Iminodiacetic
Acid Scintigraphy’’
(Ann Surg 2016;263:e35)
T he French group reported their experi-ence with technetium (Tc99m)-labled
hepatobiliary iminodiacetic acid (HIDA) scin-
tigraphy assessing interstage hepatic function
of the future liver remnant (FLR) and the
deportalized liver in patients undergoing
associating liver partition and portal vein
ligation for staged hepatectomy (ALPPS).
The report is based on a series of 5 patients
with colorectal liver metastases (n¼ 4) and
gallbladder carcinoma (n¼ 1) with right
hepatectomy in 2 cases and extended right
hepatectomy in 3 cases at stage-2 surgery.
During ALPPS interstage, the authors obser-
ved an attenuation of hepatic function in the
excluded liver and a concomitant increase of
function in the FLR but total function dropped
compared with prestage 1 function. Further-
more, percent volume increase after stage-1
surgery increasedmore pronounced compared
with increase in function.Thepatientwhodied
showed a sharp drop of function in the depor-
talized lobe whereas function of the deportal-
ized lobe remained higher than in the FLR in
all survivors.1
Truant et al state that one of the major
criticisms of ALPPS is the associated high
mortality rate, which is reported up to 12%
even by experienced centers. Especially, the
interstage function of the FLR plays an
important role and determines outcome after
stage-2 surgery.1 The letter challenges us with
the question ‘‘Does volume translate in func-
tion?’’ Obviously, volumemeasurement alone
does not appear to be the only definitive
determination whether to proceed safely with
stage-2 surgery. Therefore, there is an urgent
need for reliable and noninvasive tests to
measure regional and global liver function
during the interstage course of ALPPS. The
authors advocate HIDA scintigraphy for
adequate liver function assessment to select
patients upfront for ALPPS or to delay stage-2
surgery until adequate function is reached.
HIDA scintigraphy was frequently
used in the past as diagnostic tool for acute
cholecystitis but is today increasingly used to
assess liver function. The principle of HIDA
relies on both hepatic uptake and biliary
excretion function.2 In contrast to other
dynamic liver function tests, the main
advantage of HIDA scintigraphy is its non-
invasive ability to assess liver function for
anatomic regions of interest. In other words,
function can be separately measured for the
right and left lobe. Although the indocyanine
green clearance test can also measure func-
tion of regions of interest but this requires
invasive access for ipsi- and contralateral
inflow occlusion of the hemiliver. On the
other hand, HIDA has also limitations especi-
ally in cholestatic conditions and might
be therefore not suitable for patients with
cholangiocarcinoma.
Although the present series presents
only 5 patients, there is growing evidence in
the hepatobiliary community that noninva-
sive HIDA scintigraphy may become a stand-
ard test for functional assessment of FLR
before proceeding with major liver surgery.
A recent study by the Dutch group showed
that patients with FLR function below the
threshold of 2.69%/min/m2 had a high risk to
develop postoperative liver failure after
major hepatectomy.3 In this study, 8 of 9
patients who developed postresection liver
failure died. The prediction of postresection
liver failure using the cutoff of 2.69%/
min/m2 had a high discriminatory ability with
a c-statistic of 0.916. Whether the same
cutoff applies to the interstage ALPPS liver
function is unknown. A recently published
study on ALPPS showed that postoperative
liver failure was the leading cause for early
mortality after stage-2 surgery.4 Unfortu-
nately, Truant et al did not report on specific
functional data of the FLR. Beside the pure
qualitative description of liver function of the
deportalized liver and FLR, it would be of
high interest if the authors would have pro-
vided data on quantitative liver function in
their letter. In addition, the low case number
(n¼ 5) and the mixture of ALPPS (n¼ 3) and
salvage ALPPS (n¼ 2) are further limitations
of the report. Furthermore, it is also difficult
to draw valuable conclusions on 1 observation
with lethal outcome. However, the authors
point out a very important functional topic
in ALPPS where no data have been published
on interstage function assessment by HIDA
scintigraphy. Therefore, this topic urgently
needs further investigation to improve early
outcome and avoid futility in ALPPS.
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